TA-1 (Thymosin Alpha-1) 10mg research peptide vial by FYH Peptides
COA Verified
Immunology Research Cat№ FYH-020

TA-1 (Thymosin Alpha-1)

10mg • Lyophilized
$125.57 USD / vial

Thymosin Alpha-1 — acetylated 28-amino-acid peptide. Research-grade compound for in vitro immunology study.

Technical Data

Catalog №
FYH-020
CAS №
62304-98-7
Purity (HPLC)
99.10%
Mol. Weight
3108.30 g/mol
Mass / Vial
10mg
Form
Lyophilized
Storage
−20 °C, lyophilized
Origin
Switzerland, GMP-grade synthesis
Sequence / Structure
Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH

Certificate of Analysis

COA available on request — contact us for the latest batch report.

Add to Inquiry

💳 Card & crypto checkout is launching soon. For now, every order is arranged securely with our verified specialist on Telegram (@FYHPeptides).

Published Research

Peer-reviewed literature indexed on NCBI PubMed referencing TA-1 (Thymosin Alpha-1). Listed for laboratory reference only — FYH Peptides makes no claim regarding the conclusions of any cited author. Click PubMed or DOI to read the original publication. Updated 2026-05-20.

  1. 1.
    Thymosin alpha-1.
    Ancell CD, Phipps J, Young L
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2001
    PubMed DOI 10.1093/ajhp/58.10.886 PMID: 11381492
  2. 2.
    Aging and Thymosin Alpha-1.
    Simonova MA, Ivanov I, Shoshina NS, et al.
    International journal of molecular sciences · 2025
    PubMed DOI 10.3390/ijms262311470 PMID: 41373628
  3. 3.
    Thymosin alpha-1 treatment in chronic hepatitis B.
    Wu X, Jia J, You H
    Expert opinion on biological therapy · 2015
    PubMed DOI 10.1517/14712598.2015.1007948 PMID: 25640173
  4. 4.
    A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection.
    Shehadeh F, Benitez G, Mylona EK, et al.
    The Journal of infectious diseases · 2023
    PubMed DOI 10.1093/infdis/jiac362 PMID: 36056913
  5. 5.
    Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.
    Liaw YF
    Journal of gastroenterology and hepatology · 2004
    PubMed DOI 10.1111/j.1440-1746.2004.03633.x PMID: 15546254
  6. 6.
    Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacy.
    Liu K, Kong L, Cui H, et al.
    Cell reports. Medicine · 2024
    PubMed DOI 10.1016/j.xcrm.2024.101751 PMID: 39357524
  7. 7.
    Thymosin alpha 1: A comprehensive review of the literature.
    Dominari A, Hathaway Iii D, Pandav K, et al.
    World journal of virology · 2020
    PubMed DOI 10.5501/wjv.v9.i5.67 PMID: 33362999
  8. 8.
    Thymosin alpha 1 and HIV-1: recent advances and future perspectives.
    Matteucci C, Grelli S, Balestrieri E, et al.
    Future microbiology · 2017
    PubMed DOI 10.2217/fmb-2016-0125 PMID: 28106477
⚠️ For Research Use Only. This product is sold exclusively for in vitro laboratory research use by qualified researchers and laboratories. It is NOT intended for human consumption, medical use, or as a dietary supplement. The FDA has not evaluated this product for safety or efficacy.

Related research compounds

More compounds researchers browse alongside TA-1 (Thymosin Alpha-1).

KPV 10mg research peptide 99.00%
Immunology Research KPV 10mg $68.16
PNC-27 10mg research peptide 98.50%
Immunology Research PNC-27 10mg $132.74
Retatrutide 10mg research peptide 99.45%
Metabolic Research Retatrutide 10mg $139.92
BPC-157 10mg research peptide 99.93%
Tissue Research BPC-157 10mg $82.51
View full catalog →
$125.57 USD / vial
Add to Inquiry